These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23908512)

  • 21. Safety and efficacy of the biologic response modifiers.
    Markenson J
    Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3 Suppl):15-9. PubMed ID: 17491583
    [No Abstract]   [Full Text] [Related]  

  • 22. Rheumatoid arthritis and tumor necrosis factor alpha.
    Abe T; Takeuchi T
    Autoimmunity; 2001; 34(4):291-303. PubMed ID: 11905855
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytokines in rheumatoid arthritis: trials and tribulations.
    Carteron NL
    Mol Med Today; 2000 Aug; 6(8):315-23. PubMed ID: 10904249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental therapy of rheumatoid arthritis with antibodies to tumor necrosis factor].
    Manger B
    Z Rheumatol; 1998 Oct; 57(5):298-301. PubMed ID: 9864834
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of biological agents in the treatment of rheumatoid arthritis.
    Fan PT; Leong KH
    Ann Acad Med Singap; 2007 Feb; 36(2):128-34. PubMed ID: 17364080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
    Narazaki M; Tanaka T; Kishimoto T
    Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rheumatoid arthritis].
    Tsukamoto M; Takeuchi T
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():534-8. PubMed ID: 23513897
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinical perspective of rheumatoid arthritis.
    Scherer HU; Burmester GR
    Eur J Immunol; 2009 Aug; 39(8):2044-8. PubMed ID: 19672900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in targeted therapies V: Proceedings of the 5th International Symposium. St Martin, French West Indies. 11-14 April 2003.
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2():ii1-96. PubMed ID: 14532137
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasculitis in rheumatoid arthritis.
    Turesson C; Matteson EL
    Curr Opin Rheumatol; 2009 Jan; 21(1):35-40. PubMed ID: 19077716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis.
    Takeuchi T
    Intern Med; 2007; 46(16):1311-2. PubMed ID: 17704613
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.
    Jani M; Chinoy H; Warren RB; Griffiths CE; Plant D; Fu B; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Barton A;
    Arthritis Rheumatol; 2015 May; 67(8):2011-9. PubMed ID: 26109489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases.
    Willrich MA; Murray DL; Snyder MR
    Transl Res; 2015 Feb; 165(2):270-82. PubMed ID: 25305470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New treatments for rheumatoid arthritis].
    Girault V; Flipo RM
    Soins; 2004 Sep; (688):37-8. PubMed ID: 15515847
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspective.
    Wallis WJ; Furst DE; Strand V; Keystone E
    Rheum Dis Clin North Am; 1998 Aug; 24(3):537-65. PubMed ID: 9710886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern techniques of immunomodulation in rheumatoid arthritis.
    Codreanu C
    Roum Arch Microbiol Immunol; 1993; 52(3):149-56. PubMed ID: 7833528
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences.
    Keiserman M; Codreanu C; Handa R; Xibillé-Friedmann D; Mysler E; Briceño F; Akar S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1049-57. PubMed ID: 24961616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.
    Campion GV
    Ann Rheum Dis; 1994 Aug; 53(8):485-7. PubMed ID: 7944630
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis.
    Figueiredo-Braga M; Cornaby C; Cortez A; Bernardes M; Terroso G; Figueiredo M; Mesquita CDS; Costa L; Poole BD
    J Immunol Res; 2018; 2018():5954897. PubMed ID: 30148175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.